PGXIS has extensive experience of how pharmacogenomics can best add value to the development and commercialisation of medicines.

We work with our clients to identify the compounds in their pipelines that could benefit most from application of this technology.

We then work with them to find the most cost-effective way to incorporate the approach into their development plans.

The result optimises product pipelines and budgets for return on investment.